Additionally, utilising the TCGA Ovarian cancer cohort in UCSC Xena, we observed a non-significant trend (Supplementary Fig. 2B, p = 0.08) toward worse survival in patients with tumours that had high Mre11 copy numbers (Supplementary Fig. 2B). This evidence concerns the gene MRE11 and ovarian carcinoma.